Core BURN Ultra
Extreme Thermogenic Powder
Why does it have to be so difficult? You sit there, a bottle of pills in one hand, a tub of powder in the other, staring blankly at a seemingly endless wall of potions, tinctures, and tonics all with one purpose in mind – to improve the way your body looks, and how you feel about it.
But how do you choose? Which is the best, or the worst? For that matter, how do you even decipher what’s in the bottle in front of you, when the amount of every ingredient is masked behind a thousand promises and the ever-present, "proprietary blend.”
Confused about which "miracle breakthrough,” or "huge advance in science” to choose, you select the one that seems the most popular and go home. After three or four weeks, the only thing that’s slimmer is your wallet, and you decide that all supplements are worthless.
But what if there was a better, more effective way? What if, instead of promising "breakthroughs,” "advances,” and "revolutions,” a company simply promised clinically-effective ingredients, at clinically-effective servings? What if, instead of shouting about "secrets of the trade,” a company admitted there really wasn’t any – that the only true secret is who’s willing to spend the time, effort, and money, to deliver an amazing product. What if this company – gasp! – told you exactly what was in the product? Wouldn’t that be the better way?
Core Nutritionals’ Core BURN Ultra powder is that better way. There are no gimmicks here, no tricks and trade secrets. Just the very best, most verified-effective ingredients at serving sizes known to exert powerful effects on the human body. With Core BURN Ultra, we have taken many of the same ultra-potent ingredients found in Core BURN, mixed in a few amazing new friends, and put the whole thing in a delicious, convenient, and rapidly-dissolving powder.
In the end, it’s your choice: flashy magazine ads, or an unrivaled and extreme thermo that plain, flat-out works as promised. If we had to choose between a slim wallet or a slim waist, we’d choose the latter – because we’d choose Core BURN Ultra.
L-carnitine is a derivative of the amino acid lysine and, as certain conditions outpace the body’s ability to produce it, l-carnitine is considered a conditionally essential amino acid. While endogenous biosynthesis of l-carnitine from the amino acids lysine and methionine is sufficient for essential processes – along with dietary sources of carnitine from protein-rich red meat, for example – dietary supplementation of carnitine may pose benefits in certain physiological conditions.
Unfortunately, due to excess metabolism of l-carnitine by microorganisms in the small intestine, exogenous supplementation with oral l-carnitine has proved ineffective. ALCAR, an acetylated version of l-carnitine, has considerably higher oral bioavailability, due likely to only partial hydrolytic metabolism. Once in the bloodstream, ALCAR plays a fundamental role in the production of energy, acting as the catalyst for the beta-oxidation of long chain fatty acids by the mitochondria; regulating the CoA to Acyl-CoA ratio (necessary for the production of ATP); and the metabolism of carbohydrates. ALCAR also is an excitatory agent for neurons, increases neuronal transmission, and increases the production of neurotransmitters and neurohormones such as dopamine and serotonin.
Garcinia cambogia fruit extract (50% hydroxycitric acid):
Garcinia cambogia, more commonly known under a variety of names, including the tamarind, is a small tropical fruit endemic to Indonesia. This plant has come under increased media attention over the past few years, due largely to the purported effects of its principal constituent, hyrdoxycitric acid, or HCA.
HCA itself is a derivative of citric acid, and competitively inhibits the enzyme adenosine triphosphatase-citrate-lyase. This enzyme is an extra-mitochondrial enzyme (meaning it sits outside the mitochondria) chiefly responsible for a process known as de novo lipogenesis – or the production of fatty acids from glucose.
Green coffee extract (50% chlorogenic acid):
Chlorogenic acids are phenolic compounds created during the metabolism of various isoquinic acids found in the leaves of both coffee and tea. In addition to the well-established sympathomimetic effects of coffee and tea’s constituents, recent research has demonstrated a range of other potential benefits for compounds such as chlorogenic acids.
Recent literature suggests that the consumption of both green coffee, as well as standardized extracts of CGAs, relax the vasculature and improve vasoreactivity, impose an inhibitory effect on lipid accumulation and body weight in both mice and humans, and modulate glucose metabolism via the glucose-6-phosphate pathway.
Trials in both humans and mice using 1% extracts of green coffee bean revealed significant bodyweight reductions over periods of two and eight weeks. Researchers hypothesized that the bodyweight reductions associated with oral CGA administration was associated with the product’s numerous mechanisms of action, rather than a single, isolated cause.
Caffeine (1,3,7-trimethylxanthine) and Theobromine (3,7-dimethyl-1H-purine-2,6-dione):
Caffeine is the most widely consumed, and perhaps one of the most reviewed, psychoactive compounds. Its physiological effects in a range of areas have been well-documented, including exercise performance, information processing, alertness and mood enhancement, attention, and awareness, along with its anti-lipogenic and lipolytic abilities. Caffeine is also the most well-known in the methylxanthine compound class, the constituents of which inter-metabolize into one another in the human body and largely share similar effects.
Various clinical trials have demonstrated that xanthines – including caffeine and theobromine – exert potent lipolytic (the breakdown of fat tissue into fatty acids) and oxidative (the actual ‘burning’ of fat) actions as sympathomimetic amines. In less scientifically-complex parlance, this means caffeine is forcing your body to preferentially use fat tissue as a fuel source for the oxidative provision of ATP (your body’s energy currency).
Evidence for caffeine’s capacity as a lipolytic is widely available. In a clinical study featuring four separate trials in both normal and obese subjects, for example, caffeine was found to significantly increase fatty acid metabolism (as measured by serum fatty acid concentration), resting metabolic rate, and total fat oxidation – suggesting the preferential substrate selection spoken about above occurs in both normal and obese individuals. Other trials have demonstrated the effects of methylxanthines on total fat mass (reduction), lean body mass (increases), stamina and endurance, as well as cardiovascular capacity.
Additionally, as selective cAMP potentiators, through the beta-adrenergic pathway, caffeine and theobromine have been hypothesized to exert a synergistic effect on lipolysis when combined with forskolin.
Coleus forskohlii root extract (10% forskolin):
Coleus forskohlii is a small perennial endemic to various tropical regions in the world, including South America, sub-Saharan Africa, and India. While the West has recently taken interest in the plant due to the pharmacological properties of its primary bioactive, forskolin, Coleus forskholii preparations and tinctures have been used in both South American and African traditional folk medicinal systems, as well as extensively within Ayurveda.
Due to the ever-increasing interest in the plant’s verifiable pharmacological and physiological effects, however, Coleus forksholii and its extracted constituents have been the subject of numerous animal and human clinical trials in the past decade. These trials have demonstrated the plant to have various effects and applications, including as a lipolytic and anti-lipogenic, and as a powerful antioxidant.
A recent double-blind, randomized, and placebo-controlled human clinical trial featuring obese men found that the daily implementation of Coleus forskholii, for twelve weeks, led to significantly better weight loss outcomes as compared to controls. Overweight men in the forskolin group experienced not only improved body composition (as measured by both body fat percentage and total fat mass), but also statistically significant increases in lean body mass.
Coleus forskholii – and more specifically, forskolin – achieves this effect by rapidly, potently, and dose-dependently increasing an important metabolic enzyme known as adenylate cyclase. Adenylate cyclase is an enzyme responsible for catalyzing the formation of cyclic adenosine monophosphate (cAMP) from adenosine triphosphate (ATP). This increase in cAMP formation eventually leads to the activation of an enzyme, protein kinase A, which in turn will phosphorylate and hence activate the enzyme, Hormone Sensitive Lipase (HSL) – the rate-limiting enzyme necessary for stored triglycerides within adipocytes to be released as free fatty acids and utilized for energy.
In more basic terms, this means that forskolin quite literally frees up more fatty acids to be used as fuel for exercise – more or less the perfect scenario in a product such as Core BURN Ultra!
Bacopa monnieri (50% bacosides):
Bacopa monnieri, also known as the water hyssop commonly, or as Brahmi in Ayurvedic texts, is a small creeping herb endemic to sub-tropical India. The herb has been used in traditional Indian medicine for well over one thousand years, with its first recorded usage coming in the 6th century A.D. In this traditional context, BM has been used for a wide-range of purposes, including as a treatment of asthma and epilepsy.
More recently, BM has been the subject of numerous cognition and memory trials, as the plant has a well-established nootropic effect. Likely through modulation of the serotonin reuptake system, clinical trials in healthy humans have demonstrated that BM possesses a significant effect on the retention of newly-learned information. In several trials utilizing a 300mg daily serving, BM was also shown to decrease the recall delay of newly learned information and reduce short term forgetfulness – suggesting that the herb’s effect on the serotonic and cholinergic systems are increasing the encoding (the literal storing) of memory information.
Beyond cognition and memory encoding, BM has also been demonstrated to function as a potent adaptogen and relaxant – which in the Core BURN Ultra formula may help to smooth the effect curve of the product’s stimulants, reducing jitteriness or, "crash.”
Advantra-Z® Bitter Orange Extract (Citrus aurantium) (fruit) (50% synephrine):
Synephrine is a naturally-occurring alkaloid with adrenergic agonist activity, structurally related to epinephrine, norepinephrine, ephedrine, and other compounds with a phenethylamine base structure. Despite its chemical similarity to these compounds, synephrine in its various isomers exerts unique effects on adrenergic receptors, in particular, and the human body, in general.
Synephrine exists in three isomer forms: para-, meta- and ortho-synephrine. The molecular changes between the three isoforms are minute, but even this small change results in significant alterations to each isomer’s physiological and pharmacokinetic profile. Two of synephrine’s isomers, both p- and m-synephrine, have been shown to naturally occur in mammals (in low concentrations). As a sympathomimetic, synephrine has been the subject of numerous trials, assessing its effects on weight management, thermogenesis, metabolic rate, and caloric expenditure. In a double-blind, randomized, and placebo-controlled trial involving 10 healthy individuals, the p-synephrine isomer was administered at a 50mg serving, both alone, and in combination with hesperidin and naringin. The authors measured resting metabolic rate (RMR), blood pressure, and heart rate, along with subjective feelings of mood and energy, at baseline, and at 45-mintues and 75-minutes after ingestion. The authors reported a significant increase in RMR in each of the supplement groups, relative to placebo.
In addition to studies on synephrine in its various isomers, Advantra-Z®, the specific form of synephrine utilized in Core BURN Ultra, has itself and in combination with other ingredients, been the subject of various clinical trials in humans. In a randomized, double-blind, placebo-controlled trial featuring 70 obese adults, a formulation containing Advantra-Z® was found to significantly reduce fat mass, body weight, and hip and waist girth as compared to controls, while leading to an increase in lean mass. As the authors comment, these results are in-line with a recent systematic review of human clinical studies involving Citrus aurantium, that revealed the ingredient to reliably increase resting metabolic rate up to 7.2%, increase energy expenditure of up to 13.4%, and weight loss of over 2.9 kg, with no serious adverse events in any of the trials.
In addition, the combination of caffeine and synephrine appears to potentiate each ingredient’s effects – with rates of fatty acid liberation, heart rate, metabolic rate, and fatty acid oxidation increased in clinical trials featuring the combination. In the same systematic review mentioned above, the authors note that the combination of synephrine and caffeine led to a small but significant reduction in fat mass of 3lbs, and a reduction in bodyfat of 2.9%.
Combined with not only caffeine, but the other ingredients in Core BURN, Advantra-Z® appears to be a potent weapon in the arsenal for body composition and weight management.
PURENERGY™ (Caffeine Pterostilbene Complex)
PURENERGY™ is a highly interesting, novel new dietary ingredient created by combining caffeine (at a 43% proportion) with pTeroPure, a 99% pure all-trans pterostilbene (at 53% proportion).
Pterostilbene is, in turn, itself a highly interesting compound, and the subject of considerable excitement and clinical research within the medical community. Found in small concentrations in blueberries and grapes, pterostilbene is a dimethylated version of the well-known compound resveratrol, and as a consequence, appears to share many of its beneficial physiological effects. Pterostilbene, in addition, has been hypothesized to exert unique effects in the human body through both genomic and enzymatic pathways, including functioning as a potent antioxidant, as well as playing a role in the regulation of glycolytic/gluconeogenic enzymes such as hexokinase, glucose-6-phosphatase, and fructose-1,6-bisphosphatase.
In combination as PURENERGY™, caffeine and pterostilbene have been the subject of a single, but promising, human trial. The results from this trial demonstrated:
• PURENERGY™ delivers almost 30% more caffeine into the blood than ordinary caffeine.
• The rate of caffeine absorption is significantly slower with PURENERGY™, by about 30% as compared to ordinary caffeine
• The half-life of caffeine from PURENERGY™ is extended significantly by about 25% over that of ordinary caffeine.
• At 4 hours, there was 45% more caffeine from PURENERGY™ compared to ordinary caffeine alone
• At 6 hours, there was 51% more caffeine from PURENERGY™ compared to ordinary caffeine alone.
• At 6 hours, subjects taking PURENERGY™ showed significantly less fatigue and greater concentration compared to baseline. Ordinary caffeine did not.
• At 6 hours, subjects taking PURENERGY™ showed improved energy, alertness and focus compared to baseline. Ordinary caffeine did not.
Coupled with a lack of adverse events seen in the trial, PURENERGY™ may represent a significant leap forward in the dietary supplement field.
† Daily value not established.
Other Ingredients (Mango): Natural and Artificial Flavors, Citric Acid, Sucralose, Silicon Dioxide, Sodium Citrate, Potassium Chloride
Other Ingredients (Raspberry Lemonade): Natural and Artificial Flavors, Citric Acid, Sucralose, Silicon Dioxide, Sodium Citrate, Potassium Chloride
Directions: To assess tolerance, mix 1 scoop with 10-12 ounces of water and consume first thing in the morning. An additional 1 scoop can be taken 5-6 hours later. Once tolerance is assessed, serving can be increased to 2 scoops in the morning and 1 scoop 5-6 hours later. Do not exceed 3 scoops in a 24 hours period. Do not use longer than 8 continuous weeks without a 4 week break. Do not take with any other products or foods containing caffeine or other stimulants.
Warning: This product is only intended for use in healthy adults 18 years of age or older. Pregnant or nursing women should not use this product. Consult your healthcare provider before using this product, especially if you are taking any prescription, over the counter medication, dietary supplement product , or if you have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver, kidney or thyroid disease, seizure disorder, psychiatric disease, diabetes, difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication. Discontinue use and consult your health care professional if you experience adverse reaction to this product. Do not exceed recommended serving. Do not use in combination with caffeine or any stimulants, including but not limited to, coffee, tea, soda, and other dietary supplements or medications. Do not use under extreme conditions of heat, sleep deprivation, extreme cardiovascular exertion or dehydration. Do not combine with alcohol. Do not use if safety seal is broken or missing. Keep out of reach of children.
Alasbahi RH, Melzig MF. Plectranthus barbatus: a review of phytochemistry, ethnobotanical uses and pharmacology - Part 1. Planta Med. 2010 May;76(7):653-61.
Alasbahi RH, Melzig MF. Forskolin and derivatives as tools for studying the role of cAMP. Pharmazie. 2012 Jan;67(1):5-13.
Godard MP, et al. Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men. Obes Res. 2005 Aug;13(8):1335-43.
Henderson S, et al. Effects of coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight women. J Int Soc Sports Nutr. 2005 Dec 9;2:54-62.
Tamboli ET, et al. Metabolic diversity in Coleus forskohlii Briq. of Indian subcontinent. Nat Prod Res. 2013;27(19):1737-42.
Greenway FL, et al. Topical fat reduction. Obes Res. 1995 Nov;3 Suppl 4:561S-568S.
Shivaprasad HN, et al. Effect of Coleus forskohlii extract on cafeteria diet induced obesity in rats. Pharmacognosy Res. 2014 Jan;6(1):42-5.
Higgins HL, Means JH. The effect of certain drugs on the respiratory and gaseous metabolism in normal human subjects. J Pharmacol Exp Ther 1915;7:1–9.
Dulloo AG, Geissler CA, Horton T, Collins A, Miller DS. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr 1989;49:44 –50.
Astrup A, Buemann B, Christensen NJ, et al. The effect of ephedrine/ caffeine mixtures on energy expenditure and body composition in obese women. Metabolism 1992;41:686 – 8.
Dulloo AG, Seydoux J, Girardier L. Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition? Metabolism 1992;41: 1233– 41.
Dulloo AG, Miller DS. Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity. Am J Clin Nutr 1987;45:564 –9.
Dulloo AG, Miller DS. The thermogenic properties of ephedrine/ methylxanthine mixtures: human studies. Int J Obes 1986;10:467– 81. Astrup A, Toubro S, Thorbek G, Cannon S, Hein P, Madsen J.
Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study. Metabolism 1991;40:323–9.
Bracco D, Ferrarra J-M, Arnaud MJ, Jéquier E, Schutz Y. Effects of caffeine on energy metabolism, heart rate and methylxanthine metab- olism in lean and obese women. Am J Physiol 1995;269:E671– 8.
Bellet S, Kershbaum A, Finck EM. Response of free fatty acids to coffee and caffeine. Metabolism 1968;17:702–7.
Bellet S, Roman L, de Castro O, Kim KE, Kershbaum A. Effect of coffee ingestion on catecholamine release. Metabolism 1969;18:288 – 91.
Butcher RW, Baird CE, Sutherland EW. Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells. J Biol Chem 1968;243:1705–12.
Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR. A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol 1995;269:E649 –56.
Wolfe RR. Tracers in metabolic research: radioisotopes and stable isotopes/mass spectrometry methods. New York: Liss, 1984.
Ochiai R, Jokura H, Suzuki A, Tokimitsu I, Ohishi M, Komai N, Rakugi H, Ogihara T. Green coffee bean extract improves human vasoreactivity. Hypertens Res. 2004;27:731–7. Medline
Shimoda H, Seki E, Aitani M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med. 2006;6:1–9.
Blum J, Lemaire B, Lafay S. Effect of a green decaffeinated coffee extract on glycaemia. NutraFoods Res. 2007;6:13–7.
Song, Y.; Wang, H. J.; Ma, J.; Wang, Z. PLoS One 2013, 8, 53069.
Bolton, J. L.; Smith, S. H.; Huff, N. C.; Gilmour, M. I.; Foster, W. FASEB J. 2012, 26, 474–454.
Xia, W.; Sun, C.; Zhao, Y.; Wu, L. Phytomedicine 2011, 18, 516– 520.
Seo, D. C.; Niu, J. Int. J. Behav. Med. 2013, Jun 7.
Suzuki, Y.; Miyoshim, N.; Isemura, M. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2012, 88, 88–101.
Bazzano, L. A.; Serdula, M. K.; Liu, S. Curr. Atheroscler. Rep. 2003, 5, 492–499.
Wu, S.; Deng, F.; Hao, Y.; Shima, M.; Wang, X.; Zheng, C; Wei, H; Lv, H; Lu, X; Huang, J; Qin, Y; Guo, X. J. Hazard. Mater. 2013, 260C, 183191.
Boyle, K. E.; Zheng, D.; Anderson, E. J.; Neufer, P. D.; Houmard, J. A. Int. J. Obes. (Lond) 2012, 36, 1025–1031.
Xu, X.; Yavar, Z.; Verdin, M.; Ying, Z.; Mihai, G.; Kampfrath, T.; Wang, A.; Zhong, M.; Lippmann, M.; Chen, L. C.; Rajagopalan, S.; Sun, Q. Arterioscler. Thromb. Vase. Biol. 2010, 30, 2518–2527.
Ven Murthy MR, et al. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha. Cent Nerv Syst Agents Med Chem. (2010).
Shinomol GK, Muralidhara, Bharath MM. Exploring the role of "Brahmi" (Bocopa monnieri and Centella asiatica) in brain function and therapy. Recent Pat Endocr Metab Immune Drug Discov. (2011).
Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. (2008).
Mukherjee S, et al. Evaluation of comparative free-radical quenching potential of Brahmi (Bacopa monnieri) and Mandookparni (Centella asiatica). Ayu. (2011).
Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. (2005).
Shinomol GK, Muralidhara. Bacopa monnieri modulates endogenous cytoplasmic and mitochondrial oxidative markers in prepubertal mice brain. Phytomedicine. (2011).
Chowdhuri DK, et al. Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res. (2002).
Bhandari P, et al. Bacosterol glycoside, a new 13,14-seco-steroid glycoside from Bacopa monnieri. Chem Pharm Bull (Tokyo). (2006).
Ghosh T, Maity TK, Singh J. Antihyperglycemic activity of bacosine, a triterpene from Bacopa monnieri, in alloxan-induced diabetic rats. Planta Med. (2011).
Bhandari P, et al. A rapid RP-HPTLC densitometry method for simultaneous determination of major flavonoids in important medicinal plants. J Sep Sci. (2007).
Bhandari P, et al. Silica-based monolithic column with evaporative light scattering detector for HPLC analysis of bacosides and apigenin in Bacopa monnieri. J Sep Sci. (2009).
Deb DD, et al. In vitro safety evaluation and anticlastogenic effect of BacoMind on human lymphocytes. Biomed Environ Sci. (2008).
Murthy PB, et al. Estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography. Chem Pharm Bull (Tokyo). (2006).
Deepak M, et al. Quantitative determination of the major saponin mixture bacoside A in Bacopa monnieri by HPLC. Phytochem Anal. (2005).
Phrompittayarat W, et al. Stability studies of saponins in Bacopa monnieri dried ethanolic extracts. Planta Med. (2008).
Sairam K, et al. Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomedicine. (2001).
Goel RK, et al. In vitro evaluation of Bacopa monniera on anti-Helicobacter pylori activity and accumulation of prostaglandins. Phytomedicine. (2003).
Dorababu M, et al. Effect of Bacopa monniera and Azadirachta indica on gastric ulceration and healing in experimental NIDDM rats. Indian J Exp Biol. (2004).
Charles PD, et al. Bacopa monniera leaf extract up-regulates tryptophan hydroxylase (TPH2) and serotonin transporter (SERT) expression: implications in memory formation. J Ethnopharmacol. (2011).
Rajan KE, et al. Attenuation of 1-(m-chlorophenyl)-biguanide induced hippocampus-dependent memory impairment by a standardised extract of Bacopa monniera (BESEB CDRI-08). Neurochem Res. (2011).
Astrup A, Breum L, Toubro S, Hein P, Quaade F. 1992. The effect and safety of an
ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on
an energy restricted diet. A double blind trial. Int. J. Obes. Relat. Metab. Disord. 16(4): 269-277.
Astrup A, Toubro S. 1993. Thermogenic, metabolic, and cardiovascular responses to ephedrine
and caffeine in man. Int. J. Obes. Relat. Metab. Disord. 17(Suppl. 1): S41-S43.
Astrup A, Breum L, Toubro S. 1995. Pharmacological and clinical studies of ephedrine and other
thermogenic agonists. Obesity Res. 3(Suppl. 4): 537S-540S.
Avula B, Upparapalli SK, Navarette A, Khan IA. 2005. Simultaneous quantification of
adrenergic amines and flavonoids in C. aurantium, various Citrus species, and dietary
supplements by liquid chromatography. J. AOAC Int. 88(6): 1593-1606.
Benowitz NL. 1990. Clinical pharmacology of caffeine. Ann. Rev. Med. 41: 277-288.
Bray GA, Greenway FL. 1999. Current and potential drugs for treatment of obesity. Endocrine
Rev. 20(6): 805-875.
Bray GA, Greenway FL. 2007. Pharmacological treatment of the overweight patient. Pharmacol.
Rev. 59: 151-184.
Brent J, Wallace K, Burkhart K. 2005. Theophylline and other methyl xanthines. In: Critical
Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Elsevier Health
Blumenthal M. 1998. The Complete German Commission E Monographs: Therapeutic guide to
Herbal Medicines. Austin, TX: America Botanical Council.
Blumenthal M. 2004-2005. Bitter orange peel and synephrine. Whole Foods (March 2004) and
(March 2005), reprinted with permission by HerbalGram. URL: